Foundation For Diabetes & Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-05-2024
- Paid Up Capital ₹ 0.10 M
as on 31-05-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Revenue 3.29%
(FY 2020)
- Profit 27.18%
(FY 2020)
- Ebitda 15.94%
(FY 2020)
- Net Worth -8.78%
(FY 2020)
- Total Assets 3.55%
(FY 2020)
About Foundation For Diabetes & Health Sciences
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arundhati Kar and Tangi Patro serve as directors at the Company.
- CIN/LLPIN
U85300HR2017NPL069808
- Company No.
069808
- Company Classification
Private Not For Profit Company
- Incorporation Date
06 Jul 2017
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Foundation For Diabetes & Health Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tangi Patro  | Director | 06-Jul-2017 | Current |
| Arundhati Kar | Director | 06-Jul-2017 | Current |
Financial Performance and Corporate Structure Insights of Foundation For Diabetes & Health Sciences.
Foundation For Diabetes & Health Sciences, for the financial year ended 2020, experienced modest growth in revenue, with a 3.29% increase. The company also saw a substantial improvement in profitability, with a 27.18% increase in profit. The company's net worth dipped by a decrease of 8.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Foundation For Diabetes & Health Sciences?
Unlock access to Foundation For Diabetes & Health Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cdas Superspeciality Hospital Private LimitedActive 7 years 10 monthsArundhati Kar and Tangi Patro are mutual person
Mattea Holistics Private LimitedActive 4 years 5 monthsArundhati Kar and Tangi Patro are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Foundation For Diabetes & Health Sciences?
Unlock and access historical data on people associated with Foundation For Diabetes & Health Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Foundation For Diabetes & Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Foundation For Diabetes & Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
